期刊名称：THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
eISSN: 17597218 | ISSN: 1759720X
DESCRIPTION
- Launched in 2009
- Impact Factor: 3.450
- Ranked 12 out of 31 in Rheumatology
- Listed in PubMed and freely available via PubMed Central and the journal website, leading to broader readership
- Rigorous peer review
- Rapid publication
- Over 500,000 article views on PubMed Central in 2018
Therapeutic Advances in Musculoskeletal Disease (TAMD) is a peer-reviewed open access journal which focuses on pioneering efforts and innovative studies across all areas of rheumatology, osteoporosis and related disciplines. Please see the Aims and Scope tab for further information.
Submission information
Please see the Submission Guidelines tab for more information on how to submit your article to the journal.
Open access article processing charge (APC) information
Publication in the journal is subject to payment of an article processing charge (APC). The APC serves to support the journal and ensures that articles are freely accessible online in perpetuity under a Creative Commons licence. The APC for this journal is currently $2,000 USD. The article processing charge (APC) is payable only if your article is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Tax-exempt status can be indicated by providing appropriate registration numbers when payment is requested. Please see further details here. Contact
Please direct any queries to alex.baliani@sagepub.co.uk This journal changed its publication mode from subscription to open access in 2019.
ABSTRACTING / INDEXING
Chemical Abstracts Service (CAS)
Clarivate Analytics: Science Citation Index Expanded (SCIE)
Medscape
ProQuest
PubMed
SCOPUS
AIMS AND SCOPE
Therapeutic Advances in Musculoskeletal Disease delivers the highest quality peer-reviewed open access original research articles, reviews, and scholarly comment on pioneering efforts and innovative studies in the medical treatment of osteoporosis and rheumatic diseases such as rheumatoid arthritis, osteoarthritis, psoriatic arthritis, ankylosing spondylitis, psoriatic arthritis and other related musculoskeletal diseases. The journal has a strong clinical and pharmacological focus and is aimed at an international audience of clinicians and researchers in rheumatology, osteoporosis and related disciplines, providing an online forum for rapid dissemination of recent research and perspectives in this area.
The journal publishes review articles, original research articles, meta-analyses, systematic reviews, editorials, case reports, case series and letters to the Editor primarily. Original research manuscripts may include laboratory, animal or human/clinical studies - all phases.
Review articles include expert opinion/perspective reviews (including single-drug and drug class reviews), narrative reviews and therapeutic area reviews. Systematic reviews, meta-analyses, postmarketing and health economic and pharmacoeconomic reviews are also welcomed. The appropriate EQUATOR Network reporting guidelines should be follows (e.g. CONSORT for randomized, controlled trials and PRISMA for systematic reviews/meta-analyses). The journal endorses the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first patient enrolment. However, consistent with the AllTrials campaign, retrospectively registered trials will be considered if the justification for late registration is acceptable.
The journal adheres to a blind review process in which the reviewer's name is routinely withheld from the author unless the reviewer requests a preference for their identity to be revealed. Manuscripts are reviewed by at least two referees; a first editorial decision is generally reached within 3 weeks of submission and online publication is usually within 3 weeks of Acceptance.
Instructions to Authors
Manuscript Submission Guidelines: Therapeutic Advances in Musculoskeletal Disease
This Journal is a member of the Committee on Publication Ethics
This Journal recommends that authors follow the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals formulated by the International Committee of Medical Journal Editors (ICMJE).
Please read the guidelines below then visit the Journal’s submission site http://mc.manuscriptcentral.com/tamd to upload your manuscript. Please note that manuscripts not conforming to these guidelines may be returned. Remember you can log in to the submission site at any time to check on the progress of your paper through the peer review process.
Only manuscripts of sufficient quality that meet the aims and scope of Therapeutic Advances in Musculoskeletal Disease will be reviewed.
As part of the submission process you will be required to warrant that you are submitting your original work, that you have the rights in the work, that you are submitting the work for first publication in the Journal and that it is not being considered for publication elsewhere and has not already been published elsewhere, and that you have obtained and can supply all necessary permissions for the reproduction of any copyright works not owned by you.
Therapeutic Advances in Musculoskeletal Disease may accept submissions of papers that have been posted on pre-print servers; please alert the Editorial Office when submitting (contact details are at the end of these guidelines) and include the DOI for the preprint in the designated field in the manuscript submission system. Authors should not post an updated version of their paper on the preprint server while it is being peer reviewed for possible publication in the journal. If the article is accepted for publication, the author may re-use their work according to the journal's author archiving policy.
If your paper is accepted, you must include a link on your preprint to the final version of your paper.
- Open Access
- Article Processing charge(APC)
- What do we publish?
3.1 Aims & Scope
3.2 Article types
3.3 Writing your paper
- Editorial policies
4.1 Peer review policy
4.2 Authorship
4.3 Acknowledgements
4.4 Funding
4.5 Declaration of conflicting interests
4.6 Research ethics and patient consent
4.7 Clinical trials
4.8 Reporting guidelines
4.9 Data
- Publishing policies
5.1 Publication ethics
5.2 Contributor's publishing agreement
- Preparing your manuscript
6.1 Formatting
6.2 Artwork, figures and other graphics
6.3 Supplementary material
6.4 Reference style
6.5 English language editing services
- Submitting your manuscript
7.1 ORCID
7.2 Information required for completing your submission
7.3 Permissions
- On acceptance and publication
8.1 SAGE Production
8.2 Online First publication
8.3 Access to your published article
8.4 Promoting your article
- Further information
Editorial Board
| Shreyasee Amin |
Mayo Clinic, Rochester, MN, USA |
| Mohit Bhandari |
McMaster University, Hamilton, ON, Canada |
| Gerolamo Bianchi |
La Colletta Hospital, Arenzano, Italy |
| Chad S. Boomershine |
Vanderbilt University, Nashville, TN, USA |
| Mary Bouxsein |
Beth Israel Deaconess Medical Center, Boston, MA, USA |
| Juliet E Compston |
Cambridge University, Cambridge, UK |
| Dieter Felsenberg |
Charité University Medicine Berlin, Berlin, Germany |
| Piet Geusens |
University Hospital, Maastricht, Netherlands |
| Dinesh Kumbhare |
McMaster University, Toronto, ON, Canada |
| Willem Lems |
VU University Medical Center, Amsterdam, Netherlands |
| Ken Lyles |
Duke University School of Medicine, Durham, NC, USA |
| Johanne Martel-Pelletier |
University of Montreal, Montreal, QC, Canada |
| Fergus McKiernan |
Marshfield Clinic, Marshfield, WI, USA |
| Terence O'Neill |
Manchester University, Manchester, UK |
| Phillipe Orcel |
University Hospital Lariboisiere, Paris, France |
| Adolfo Diez Perez |
Autonomous University of Barcelona, Barcelona, Spain |
| Jean-Yves Reginster |
Bone and Cartilage Mebolism Unit, Liege, Belgium |
| Rene Rizzoli |
University Hospitals and Faculty of Medicine of Geneva, Geneva, Switzerland |
| Stuart Silverman |
The Osteoporosis Medical Center, Beverly Hills, CA, USA |
| Jasvinder A. Singh |
University of Alabama, Birmingham, AL, USA |
| Bobo Tanner |
Vanderbilt University, Nashville, TN, USA |
|
刊名字顺( Alphabetical List of Journals):
返回页首 